Lumi Health's Intelligent Care Platform utilizes AI and real-time patient data to optimize medication selection and dosages for heart failure patients, significantly reducing the time required for physicians to make critical adjustments. By identifying patients at risk of deterioration up to one year in advance, the platform enhances clinical outcomes and minimizes unnecessary healthcare spending.
Funding
$250K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Heart failure patients often experience suboptimal medication management due to the complexities of medication selection and dosage adjustments, leading to poor clinical outcomes and increased healthcare costs. Physicians face challenges in efficiently optimizing medication strategies due to the need to synthesize large volumes of patient data and the time-consuming nature of traditional adjustment methods.
Solution
Lumi Health offers an Intelligent Care Platform designed to streamline and enhance medication management for heart failure patients. The platform leverages artificial intelligence and real-time patient data, including claims, clinical records, and patient-generated biomarkers, to identify and recommend personalized medication strategies and dosage improvements. By applying machine learning algorithms, Lumi Health continuously identifies patients at risk of deterioration, enabling timely and effective interventions. The platform establishes learning feedback loops informed by real-time insights on how patients respond to medication adjustments, facilitating rapid-cycle, continuous insight for physicians. This approach collapses physician response times from months to hours, improving patient outcomes and reducing unnecessary healthcare spending.
Target Audience
Lumi Health's primary target audience includes physicians and healthcare providers involved in the care of heart failure patients, as well as value-based care organizations seeking to improve patient outcomes and reduce costs.
Features
- AI-driven recommendations for medication selection and dosage adjustments based on evidence-based guidelines
- Continuous patient risk stratification using machine learning to identify patients needing immediate intervention
- Integration of patient-generated biomarkers, symptomatology data, and clinical progression insights for comprehensive monitoring
- Real-time feedback loops to track patient responses to medication adjustments
- Integration with peripheral and implanted devices for predictive biomarker data
- Prioritization of patients with urgent needs for effective interventions